Global /China /Healthcare /Biotechnology /ZYBT
chevron_leftBack
Zhengye Biotechnology Holding Ltd. logo

Zhengye Biotechnology Holding Ltd.

ZYBT
NASDAQ: ZYBT Delayed
0.8700USD -5.7%
As of 14 June 2026, Zhengye Biotechnology Holding Ltd. has a market cap of $41.23M USD, ranking #31925 globally and #6125 in China. It ranks #2887 in the Healthcare sector, and #559 in the Biotechnology industry.
Global Rank
31925
Country Rank
6125
Sector Rank
2887
Industry Rank
559
Key Stats
Market Cap
$41.23MUSD
Enterprise Value
$49.04MUSD
Revenue (TTM)
$21.46MUSD
EBITDA (TTM)
-$308.91KUSD
Net Income (TTM)
-$2.7MUSD
EBITDA Margin
-1.4%
Profit Margin
-13%
PS Ratio
2.0
PB Ratio
1.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Songlin Song open_in_new
Employees
277
Founded
2004
IPO
07 Jan 2025
Website
jlzybio.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-5.7% -5.4% 3.2% -13% -60% -94%

News

Loading...

ZYBT Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
ZYBT
正业生物科技控股有限公司
ISIN: KYG989MS1016
Shares Out.:
10.965M1 Shares Float: 7.709M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
0.8700 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Zhengye Biotechnology Holding Ltd.

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for household animals. In addition, it exports its products to Vietnam, Pakistan, and Egypt. The company serves direct-end customers, including livestock farmers and local governments, as well as domestic distributors and exporting distributors. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Similar Companies

Industry: Biotechnology (China)
Name
Market Cap diff.
PE
$17.44B
136.71B HKD
42K%
25.3
$12.2B
95.58B HKD
29K%
22.1
$8.0B
54.23B CNY
19K%
34.4
$7.33B
49.69B CNY
18K%
-
1530
$7.08B
55.5B HKD
17K%
5.8
$6.72B
45.52B CNY
16K%
61.6
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
AMGN
$182.42B
442K%
23.9
GILD
$159.92B
388K%
19.0
ARGX
$47.84B
41.39B EUR
116K%
39.9
$44.84B
68.19T KRW
109K%
35.5
CSL
$42.36B
60.27B AUD
103K%
29.3
LONN
$42.3B
33.71B CHF
102K%
37.2
chevron_leftBack